ESC Premium Access

Combined ARNI and SGLT2i impacts on peak tricuspid regurgitant velocity and echocardiographic probability of pulmonary hypertension

Congress Presentation

About the speaker

Doctor Marco Stracqualursi

University of Milan, Milan (Italy)
0 follower

8 more presentations in this session

Effects of beta blockers on outcome in patients with PAH with and without comorbid conditions: a Multicenter Prospective Cohort Study (BNP-PL).

Speaker: Doctor M. Waligora (Krakow, PL)

Thumbnail

The safety and efficacy of treprostinil for the treatment of pulmonary arterial hypertension: a systematic review and meta-analysis of randomized controlled trials

Speaker: Mr H. Khasawneh (Irbid, JO)

Thumbnail

Efficacy and tolerability of triple sequential combination therapies with selexipag in patients with pulmonary arterial hypertension : insights from a single-centre study

Speaker: Doctor H. Tokgoz (Istanbul, TR)

Thumbnail

Metoprolol therapy in patients with Eisenmenger syndrome (MINES) study. A single-centre, double-blinded, randomised, placebo-controlled trial

Speaker: Doctor A. Pius (New Delhi, IN)

Thumbnail

Efficacy of specific drug class therapy in pulmonary arterial hypertension associated with HIV, portal hypertension or both: a single Center experience

Speaker: Doctor F. Cennerazzo (Bologna, IT)

Thumbnail

Access the full session

Current pharmacological treatments for pulmonary hypertension

Speakers: Doctor M. Stracqualursi, Doctor M. Waligora, Mr H. Khasawneh, Doctor H. Tokgoz, Doctor A. Pius...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations